Molecular therapy for Myocardial Infarction: Candesartan, an angiotensin II receptor blocker, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 6/November/2018, 10.16  pm

"Help us make a difference by supporting our mission with your generous donation."

Spread the love


Spread the love
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!